Japan says profits from US investments in trade deal to be shared according to contributions

Japan has clarified the profit-sharing mechanism for its $550 billion investment package with the U.S., stating that returns will be split 10% for Japan and 90% for the U.S. based on the respective levels of contribution and risk borne by each side. This contradicts earlier White House claims that the U.S. would retain 90% of profits solely from Japanese investments, implying significant U.S. financial involvement in the scheme. The package, backed by state-owned Japan Bank for International Cooperation (JBIC) and Nippon Export and Investment Insurance (NEXI), aims to bolster resilient supply chains in critical sectors like pharmaceuticals and semiconductors.

Analysis

The Japanese government has provided critical clarification regarding the profit-sharing structure of its $550 billion investment package with the U.S., which is linked to a recent tariff agreement. While the 90/10 profit split favoring the U.S. was confirmed, a Japanese official stipulated that this division is contingent upon the 'respective levels of contribution and risk borne by each side.' This detail significantly reframes the deal from a unilateral Japanese investment into a co-investment scheme, implying substantial capital or risk contribution will be required from the U.S. government or American companies. The structure of this scheme, however, remains largely undefined, creating uncertainty around its execution. The package is strategically designed to bolster supply chain resilience for Japanese firms in critical sectors like pharmaceuticals and semiconductors, with financing facilitated by state-owned entities Japan Bank for International Cooperation (JBIC) and Nippon Export and Investment Insurance (NEXI). A 2023 legal revision enabling JBIC to lend to foreign companies integral to Japan’s supply chains provides the regulatory foundation for these cross-border investments.

Key Decisions for Investors

• Investors should identify and monitor Japanese and U.S. companies in the pharmaceutical and semiconductor sectors, as they are the stated primary beneficiaries of the $550 billion supply chain investment package.
• Given the deal's structure remains largely unclear, it is crucial to watch for further official announcements from both governments clarifying the specific contribution requirements and funding mechanisms, as these details will determine the true beneficiaries and financial impact.
• Consider the long-term strategic implications of this deal, as it links tariff relief to supply chain security, potentially reducing geopolitical risk for Japanese exporters in key industries and making them more resilient investments.